drugset / Trial / NCT01057498
Safety Study of Nebulized RNS60 to Treat Asthma.
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is two-fold. First, to determine whether nebulized RNS60 is safe in healthy human subjects and in subjects with mild asthma, in a single-dose administration. Second, to determine whether nebulized RNS60 is safe in human subjects with mild-to-moderate asthma over a 4-week period.
Timeline
- Start
- 2010-05
- Primary completion
- 2010-11
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RNS60 | Other / unclassified | 4 ml | Other |